ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.64
0.22%
US Tech 100
20,266.40
0.33%
S&P 500
5,969.34
0.35%
US Dollar vs CAD
1.39805
0.00%
Bitcoin
98,503.97
0.74%
Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. USOTC

  6. Agentix Corporation (PK) (AGTX) Share Price

Agentix Corporation (PK)

Agentix Corporation (PK) (AGTX)

USOTC
0.15
0.1139
(315.51%)
Closed November 24 3:00PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.15
Bid
0.12
Ask
0.50
Volume
127,449
0.097 Day's Range 0.24
0.021 52 Week Range 0.24
Market Cap
6.01M
Previous Close
0.0361
Open
0.15
Last Trade
1450
@
0.15
Last Trade Time
Financial Volume
US$ 21,873
VWAP
0.171623
Average Volume (3m)
18,826
Shares Outstanding
40,066,931
Dividend Yield
-
PE Ratio
-10.27
Earnings Per Share (EPS)
-0.01
Revenue
-
Net Profit
-585k

About Agentix Corporation (PK)

(OTC:AGTX), is a clinical-stage biotechnology company that is pursuing the development of a comprehensive suite of novel, science-driven, biopharmaceuticals that target the endocannabinoid system across multiple therapeutic areas with greater market exclusivity, for the treatment of metabolic diseas... (OTC:AGTX), is a clinical-stage biotechnology company that is pursuing the development of a comprehensive suite of novel, science-driven, biopharmaceuticals that target the endocannabinoid system across multiple therapeutic areas with greater market exclusivity, for the treatment of metabolic diseases; including Type 2 Diabetes Mellitus, Chronic Obesity, Non-alcoholic Fatty Liver Disease (NAFLD), and Non-alcoholic Steatohepatitis (NASH). AGENTIX acquired specific assets and licensing rights, including licensing rights associated with intellectual property as part of Worldwide Exclusive Agreements with NHRI (National Heath Research Institute) and RTI (Research Triangle Institute) International. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
www.agentixcorp.com
Headquarters
Carson City, Nevada, USA
Founded
-
Agentix Corporation (PK) is listed in the Biological Pds,ex Diagnstics sector of the OTCMarkets with ticker AGTX. The last closing price for Agentix (PK) was US$0.04. Over the last year, Agentix (PK) shares have traded in a share price range of US$ 0.021 to US$ 0.24.

Agentix (PK) currently has 40,066,931 shares outstanding. The market capitalization of Agentix (PK) is US$1.45 million. Agentix (PK) has a price to earnings ratio (PE ratio) of -10.27.

Ask ADVFN Intelligence (AI)

AGTX Latest News

More News

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 18 2024
Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

November 14 2024
Edgar (US Regulatory)

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

August 30 2024
Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

August 15 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

February 14 2024
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

November 20 2023
Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

November 14 2023
Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

August 22 2023
Edgar (US Regulatory)

Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB

August 14 2023
Edgar (US Regulatory)

Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405

June 29 2023
Edgar (US Regulatory)
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
1000.150.240.036120000.0361CS
4000.150.240.036120000.0361CS
120.106240.9090909090.0440.240.0361188260.05668968CS
260.11455323.1311706630.035450.240.0261126270.04739313CS
520.11783366.2729250850.032170.240.021172780.03911873CS
156-0.652-81.29675810470.8021.240.02155300.09550711CS
260-2.27-93.80165289262.4250.000140050.371037CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
NEPTFNeptune Wellness Solutions Inc (CE)
US$ 0.0238
(2,379,900.00%)
13.46k
CNVIFConavi Medical Corporation (PK)
US$ 0.58
(82,757.14%)
2.25k
FUNFFFansUnite Entertainment Inc (CE)
US$ 0.00055
(54,900.00%)
342.7k
RQHTFReliq Health Technologies Inc (CE)
US$ 0.0003
(29,900.00%)
219.11k
ELOXEloxx Pharmaceuticals Inc (CE)
US$ 0.0001
(9,900.00%)
1.53k
FDVXFFenixOro Gold Corporation (CE)
US$ 0.000001
(-100.00%)
10k
TMPOQTempo Automation Holdings Inc (CE)
US$ 0.000001
(-99.98%)
200
HLLPFHello Pal International Inc (CE)
US$ 0.000001
(-99.90%)
6k
MOTSMotus GI Holdings Inc (CE)
US$ 0.000001
(-99.88%)
649
BTAEFBeta Energy Corporation (CE)
US$ 0.000001
(-99.67%)
655
RSHNRushNet Inc (PK)
US$ 0.00015
(-25.00%)
502.31M
EARIEntertainment Arts Research Inc (PK)
US$ 0.0001
(0.00%)
428.38M
ASTAAstra Veda Corporation (PK)
US$ 0.0002
(-33.33%)
364.38M
RDARRaadr Inc (PK)
US$ 0.0009
(50.00%)
276.07M
CGACCode Green Apparel Corp (PK)
US$ 0.00065
(44.44%)
225.16M

Discussion

View Full Feed
knrorrel knrorrel 10 minutes ago
no chance in the quantum hype, $10 could come quickly now, like on Friday with qmco (+171%, only on Friday increased from $3.60 to $11!)

and it's a shame that they couldn't buy more,

but I feel the same way (I also have far too little of $QBTS but unfortunately I don'
QBTS
chen1992 chen1992 25 minutes ago
https://youtu.be/PaMsc8z1Ls4?si=u3MwvbGovNMyWXI6


Inverse Cramer at it again! Did it for TELL!!!!
TGLO
silkmaster silkmaster 27 minutes ago
It looks like we can only guss what would the pps will look like in a week/month or a year from now .
Mean while lets play what would the PPS look like come 30/11/24 so long as KT will come out and talk to the public by than that is ...

A. 0.09 (around current pps)
B. 0.
KBLB
ZLAZARUS ZLAZARUS 40 minutes ago
Ph3 melanoma data for IO102-IO103 remain on track for 1H25 and represents the next key catalyst. At .70 we are trading at cash. With a positive Ph3 melanoma readout we will be trading at $3.00 overnight with a march to $6.00 towards the later half of 2025. In addition, I'm encouraged by the support
IOBT
knrorrel knrorrel 44 minutes ago
https://de.tradingview.com/chart/Mq3nUQ7Y/?symbol=NYSE%3AQBTS
QBTS
knrorrel knrorrel 49 minutes ago
friday +171% / $11 and $Q_BTS follows on Monday, which is much better than QMCO and still has a lot of potential to trade above $10 ?
all only imho

here: https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175432596


QMCO
Whalatane Whalatane 59 minutes ago
Yes There will be less of a reaction in the UNCY stock for the reason you mentioned
ARDX is saying they will supply Xphozah free of charge to Medicare patients who lose coverage in Jan ...for the first 2 mths only
Nephrologists are probably already pulling back from starting Medicare
ARDX UNCY
SCAMBUSTERKING SCAMBUSTERKING 60 minutes ago
My statements are backed up by the court docs filed by Jake and his lawyer... then even more proven by the actions of Jake.
BCAP
Dodger1 Dodger1 1 hour ago
No Matter what. You all know you do family? Allegiances?

Alex Jones for Atty General...for sure.

Go $AABB
AABB
chereb19 chereb19 1 hour ago
An even bigger Whopper of a lie. Can't believe anything you write, there's are too many examples of your lies. Dishonest and incompetent?
RDGL
knrorrel knrorrel 1 hour ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
weedtrader420 weedtrader420 1 hour ago
☝️🤑☝️📈🚀
SUKUUSD
knrorrel knrorrel 1 hour ago
THE $QBTS TREND https://stockcharts.com/sc3/ui/?s=QBTS
QBTS
fuagf fuagf 1 hour ago
And all should understand subsidies discourage innovation leading to efficiency.
You're right too, we are talking about corporate farming in that respect also.
Ray_137 Ray_137 2 hours ago
That can be true plan 7 contains some parts of plan6. Investors in WAMU signed releases based on plan7.
COOP
Kam8 Kam8 2 hours ago
I am guessing $2+ after approval in UK, not only 27cents. 
NWBO
dstock07734 dstock07734 2 hours ago
George,

It could be none of them.
NWBO
snoopycomic snoopycomic 2 hours ago
Dufus- OS is the measurement.
NWBO
snoopycomic snoopycomic 2 hours ago
OS is the measurement fugue. Get with the program
NWBO
Dallas-Cowboys Dallas-Cowboys 2 hours ago
Natural gas and nuclear (a lot longer timeframe) are the answer to the massive Datacenters that are being constructed for AI. They already consume 100's of megawatts soon to be gigawatts of power. They use the equivalent consumption of neighborhoods and towns. Cranmer is a showman and sometimes Bozo
TGLO
236T568 236T568 2 hours ago
Good stuff

https://x.com/IanJaeger29/status/1860460658094903433?s=19

Your Recent History

USOTC
AGTX
Agentix (PK)
FX
USDMOP
US Dollar vs MOP
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved